ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection
March 08, 2021 Over the long term, patients who survive an aortic dissection appear to do just as well treated with either beta-blockers or ACE inhibitors/ARBs rather than other antihypertensive drugs, a retrospective analysis suggests. Compared with other drug classes, beta-blockers and ACE inhibitors/ARBs each were associated with lower risks of all-cause hospital readmission and all-cause mortality over a span of up to 12 years, according to researchers led by Shao-Wei Chen, MD, PhD (Linkou ...
Tainan Municipality Shao Wei Chen Chang Gung University Md University Of Michigan Phd Linkou Medical Center National Health Insurance Research Database
Source: tctmd.com